Skip to contentR
Rigel Pharmaceuticals Inc
R
RIGLRigel Pharmaceuticals Inc Released Mar 4, 2014, during market hours
10-K filed Mar 4, 2014, 63 days after period end · 0001047469-14-001756
Q4 2013 · 10-K
Revenue—
Net income—
EPS Diluted-$0.19-$0.19N/M vs Q4 2012 No earnings release is on file for this quarter. Its figures came with the 10-K.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
N/M vs Q3 2013
Operating Incomederived-$16,944,000N/M Operating Cash Flowderived-$18,886,000N/M Free Cash Flowderived-$19,054,000N/M Filing lag
ended Dec 31, 2013 · filed Mar 4, 2014 · 63 d after period end
+6.0% from the close of Mar 3, 2014 to the close of Mar 4, 2014, the first after the release.
during market hours$3.49$3.70 Feb 5Mar 4Mar 26